DRUG

compound 7c

1 hypothesis across 1 therapeutic domain

ALL HYPOTHESES

Repurposing candidates for compound 7c

Multiple sclerosis 1

Mediator Outcome Score Tier Lit. status Trial
IL-33 relapsing-remitting multiple sclerosis 0.220 Mid novel signal none

Clinical trials

0 registered trials for compound 7c

Source: ClinicalTrials.gov

No registered trials found on ClinicalTrials.gov. This could indicate either an unexplored indication or a gap in registry coverage.

Search ClinicalTrials.gov →